CJC-1295
Long-acting GHRH analog for sustained growth hormone elevation
🛑 WADA Banned 39 views
🛑 WADA BANNED - Prohibited in competitive sports as growth hormone releasing agent
Overview
CJC-1295 is a synthetic peptide that stimulates your pituitary gland to produce growth hormone. What makes it special is its extended duration — while natural growth hormone-releasing hormone lasts only minutes, CJC-1295 can keep working for up to two weeks. **How does it work?** CJC-1295 uses "Drug Affinity Complex" (DAC) technology — essentially, it attaches to albumin (a protein in your blood), which dramatically extends how long it stays active in your body. This means sustained, steady growth hormone elevation rather than quick spikes. **What the research shows:** • Increases growth hormone levels in a more natural, pulsatile pattern • May support lean muscle growth and fat metabolism • Could improve recovery and sleep quality • Often combined with Ipamorelin for synergistic effects **CJC-1295 vs. Mod GRF 1-29:** You might see "CJC-1295 without DAC" or "Mod GRF 1-29" — this is a shorter-acting version requiring more frequent dosing but offering more control over GH pulses. **Typical use:** Injected subcutaneously, usually 1-2 times per week for the DAC version, or 2-3 times daily for the non-DAC version. **Important to know:** CJC-1295 is banned by WADA and not FDA-approved for any medical condition. Human clinical data remains limited. --- **Sources:** Teichman SL, et al. (2006) Journal of Clinical Endocrinology & Metabolism | Journal of Pharmaceutical and Biomedical Analysis (2022). DOI:10.1016/j.jpba.2022.114726

Quick Facts
Formula:C165H269N47O46
Molecular Weight:3647.19
Sequence:Maleimidopropionyl
Mechanism:GHRH analogue with extended half-life
⚠️ Safety Information
Research compound only. Limited human safety data available.
Research Citations
Prolonged stimulation of growth hormone (GH) and insulin-like growth factor I secretion by CJC-1295, a long-acting analog of GH-releasing hormone, in healthy adults.
Teichman SL, Neale A, Lawrence B, Gagnon C, Castaigne JP, Frohman LA (2006)
Netnography of Female Use of the Synthetic Growth Hormone CJC-1295: Pulses and Potions.
Van Hout MC, Hearne E (2016)
A method for confirming CJC-1295 abuse in equine plasma samples by LC-MS/MS.
Timms M, Ganio K, Steel R (2019)
+ 21 more citations